Corrigendum

Ebola VP40 in exosomes can cause immune cell dysfunction [Front. Microbiol., 7, (2016), (1765)] doi: 10.3389/fmicb.2016.01765

Michelle L. Pleet, Allison Mathiesen, Catherine DeMarino, Yao A. Akpamagbo, Robert A. Barclay, Angela Schwab, Sergey Iordanskiy, Gavin C. Sampey, Benjamin Lepene, Philipp A. Ilinykh, Alexander Bukreyev, Sergei Nekhai, M. Javad Aman, Fatah Kashanchi

    Research output: Contribution to journalComment/debate

    Abstract

    In the original publication, Philipp A. Ilinykh and Alexander Bukreyev were not included as authors. The omission of these authors was a miscommunication among proteomics colleagues. Secondly, there should be a change to Materials and Methods section. In the subsection "Identification of Potential Phosphorylation Sites in VP40 Protein," in the first paragraph, the first sentence should read as follows: "Mass spectra for VP40 was obtained for this manuscript as previously described in our analysis of VP30 from EBOV virions (Ilinykh et al., 2014). Proteomics data for VP40 had not been previously published." For the third amendment, proteomics data on EBOV virions were mentioned as published whereas these data were not yet published. A correction should be made to Results section. In the sub-section "Ebola VP40 is Phosphorylated by Cyclin-Dependent Kinase 2," in the first paragraph, the sentence should read as follows: "Using our mass spectrometry data of EBOV virions we found Ser-233, Thr-272, Thr-277, and Ser-278 to be potentially phosphorylated (Figures 4A, B). The whole phosphoproteomic analysis of EBOV is ongoing and will be published elsewhere (data not shown)." The authors apologize and state that these corrections do not change the scientific conclusions of the article in any way. The original article has been updated.

    Original languageEnglish (US)
    Article number692
    JournalFrontiers in Microbiology
    Volume9
    Issue numberAPR
    DOIs
    StatePublished - Apr 17 2018

    Fingerprint

    Exosomes
    Virion
    Proteomics
    Cyclin-Dependent Kinase 2
    Publications
    Mass Spectrometry
    Phosphorylation
    corrigendum
    Proteins

    Keywords

    • Apoptosis
    • Ebola virus
    • EBOV
    • ESCRT
    • Exosomes
    • MicroRNA
    • VLP
    • VP40

    ASJC Scopus subject areas

    • Microbiology
    • Microbiology (medical)

    Cite this

    Corrigendum : Ebola VP40 in exosomes can cause immune cell dysfunction [Front. Microbiol., 7, (2016), (1765)] doi: 10.3389/fmicb.2016.01765. / Pleet, Michelle L.; Mathiesen, Allison; DeMarino, Catherine; Akpamagbo, Yao A.; Barclay, Robert A.; Schwab, Angela; Iordanskiy, Sergey; Sampey, Gavin C.; Lepene, Benjamin; Ilinykh, Philipp A.; Bukreyev, Alexander; Nekhai, Sergei; Aman, M. Javad; Kashanchi, Fatah.

    In: Frontiers in Microbiology, Vol. 9, No. APR, 692, 17.04.2018.

    Research output: Contribution to journalComment/debate

    Pleet, ML, Mathiesen, A, DeMarino, C, Akpamagbo, YA, Barclay, RA, Schwab, A, Iordanskiy, S, Sampey, GC, Lepene, B, Ilinykh, PA, Bukreyev, A, Nekhai, S, Aman, MJ & Kashanchi, F 2018, 'Corrigendum: Ebola VP40 in exosomes can cause immune cell dysfunction [Front. Microbiol., 7, (2016), (1765)] doi: 10.3389/fmicb.2016.01765', Frontiers in Microbiology, vol. 9, no. APR, 692. https://doi.org/10.3389/fmicb.2018.00692
    Pleet, Michelle L. ; Mathiesen, Allison ; DeMarino, Catherine ; Akpamagbo, Yao A. ; Barclay, Robert A. ; Schwab, Angela ; Iordanskiy, Sergey ; Sampey, Gavin C. ; Lepene, Benjamin ; Ilinykh, Philipp A. ; Bukreyev, Alexander ; Nekhai, Sergei ; Aman, M. Javad ; Kashanchi, Fatah. / Corrigendum : Ebola VP40 in exosomes can cause immune cell dysfunction [Front. Microbiol., 7, (2016), (1765)] doi: 10.3389/fmicb.2016.01765. In: Frontiers in Microbiology. 2018 ; Vol. 9, No. APR.
    @article{631deeb018eb4a3b9a783fdc60ea665e,
    title = "Corrigendum: Ebola VP40 in exosomes can cause immune cell dysfunction [Front. Microbiol., 7, (2016), (1765)] doi: 10.3389/fmicb.2016.01765",
    abstract = "In the original publication, Philipp A. Ilinykh and Alexander Bukreyev were not included as authors. The omission of these authors was a miscommunication among proteomics colleagues. Secondly, there should be a change to Materials and Methods section. In the subsection {"}Identification of Potential Phosphorylation Sites in VP40 Protein,{"} in the first paragraph, the first sentence should read as follows: {"}Mass spectra for VP40 was obtained for this manuscript as previously described in our analysis of VP30 from EBOV virions (Ilinykh et al., 2014). Proteomics data for VP40 had not been previously published.{"} For the third amendment, proteomics data on EBOV virions were mentioned as published whereas these data were not yet published. A correction should be made to Results section. In the sub-section {"}Ebola VP40 is Phosphorylated by Cyclin-Dependent Kinase 2,{"} in the first paragraph, the sentence should read as follows: {"}Using our mass spectrometry data of EBOV virions we found Ser-233, Thr-272, Thr-277, and Ser-278 to be potentially phosphorylated (Figures 4A, B). The whole phosphoproteomic analysis of EBOV is ongoing and will be published elsewhere (data not shown).{"} The authors apologize and state that these corrections do not change the scientific conclusions of the article in any way. The original article has been updated.",
    keywords = "Apoptosis, Ebola virus, EBOV, ESCRT, Exosomes, MicroRNA, VLP, VP40",
    author = "Pleet, {Michelle L.} and Allison Mathiesen and Catherine DeMarino and Akpamagbo, {Yao A.} and Barclay, {Robert A.} and Angela Schwab and Sergey Iordanskiy and Sampey, {Gavin C.} and Benjamin Lepene and Ilinykh, {Philipp A.} and Alexander Bukreyev and Sergei Nekhai and Aman, {M. Javad} and Fatah Kashanchi",
    year = "2018",
    month = "4",
    day = "17",
    doi = "10.3389/fmicb.2018.00692",
    language = "English (US)",
    volume = "9",
    journal = "Frontiers in Microbiology",
    issn = "1664-302X",
    publisher = "Frontiers Media S. A.",
    number = "APR",

    }

    TY - JOUR

    T1 - Corrigendum

    T2 - Ebola VP40 in exosomes can cause immune cell dysfunction [Front. Microbiol., 7, (2016), (1765)] doi: 10.3389/fmicb.2016.01765

    AU - Pleet, Michelle L.

    AU - Mathiesen, Allison

    AU - DeMarino, Catherine

    AU - Akpamagbo, Yao A.

    AU - Barclay, Robert A.

    AU - Schwab, Angela

    AU - Iordanskiy, Sergey

    AU - Sampey, Gavin C.

    AU - Lepene, Benjamin

    AU - Ilinykh, Philipp A.

    AU - Bukreyev, Alexander

    AU - Nekhai, Sergei

    AU - Aman, M. Javad

    AU - Kashanchi, Fatah

    PY - 2018/4/17

    Y1 - 2018/4/17

    N2 - In the original publication, Philipp A. Ilinykh and Alexander Bukreyev were not included as authors. The omission of these authors was a miscommunication among proteomics colleagues. Secondly, there should be a change to Materials and Methods section. In the subsection "Identification of Potential Phosphorylation Sites in VP40 Protein," in the first paragraph, the first sentence should read as follows: "Mass spectra for VP40 was obtained for this manuscript as previously described in our analysis of VP30 from EBOV virions (Ilinykh et al., 2014). Proteomics data for VP40 had not been previously published." For the third amendment, proteomics data on EBOV virions were mentioned as published whereas these data were not yet published. A correction should be made to Results section. In the sub-section "Ebola VP40 is Phosphorylated by Cyclin-Dependent Kinase 2," in the first paragraph, the sentence should read as follows: "Using our mass spectrometry data of EBOV virions we found Ser-233, Thr-272, Thr-277, and Ser-278 to be potentially phosphorylated (Figures 4A, B). The whole phosphoproteomic analysis of EBOV is ongoing and will be published elsewhere (data not shown)." The authors apologize and state that these corrections do not change the scientific conclusions of the article in any way. The original article has been updated.

    AB - In the original publication, Philipp A. Ilinykh and Alexander Bukreyev were not included as authors. The omission of these authors was a miscommunication among proteomics colleagues. Secondly, there should be a change to Materials and Methods section. In the subsection "Identification of Potential Phosphorylation Sites in VP40 Protein," in the first paragraph, the first sentence should read as follows: "Mass spectra for VP40 was obtained for this manuscript as previously described in our analysis of VP30 from EBOV virions (Ilinykh et al., 2014). Proteomics data for VP40 had not been previously published." For the third amendment, proteomics data on EBOV virions were mentioned as published whereas these data were not yet published. A correction should be made to Results section. In the sub-section "Ebola VP40 is Phosphorylated by Cyclin-Dependent Kinase 2," in the first paragraph, the sentence should read as follows: "Using our mass spectrometry data of EBOV virions we found Ser-233, Thr-272, Thr-277, and Ser-278 to be potentially phosphorylated (Figures 4A, B). The whole phosphoproteomic analysis of EBOV is ongoing and will be published elsewhere (data not shown)." The authors apologize and state that these corrections do not change the scientific conclusions of the article in any way. The original article has been updated.

    KW - Apoptosis

    KW - Ebola virus

    KW - EBOV

    KW - ESCRT

    KW - Exosomes

    KW - MicroRNA

    KW - VLP

    KW - VP40

    UR - http://www.scopus.com/inward/record.url?scp=85045727607&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85045727607&partnerID=8YFLogxK

    U2 - 10.3389/fmicb.2018.00692

    DO - 10.3389/fmicb.2018.00692

    M3 - Comment/debate

    VL - 9

    JO - Frontiers in Microbiology

    JF - Frontiers in Microbiology

    SN - 1664-302X

    IS - APR

    M1 - 692

    ER -